(NewsNation) — A widely prescribed GLP-1 drug may do more than improve metabolic health, according to new research.
Semaglutide — sold under brand names such as Ozempic and Wegovy — has already been linked to reduced risks for several health…
Continue Reading
News Source: www.yahoo.com

Leave a Reply